Stock MD PEDIATRIX MEDICAL GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-10 pm EDT 		5-day change 1st Jan Change
8.22 USD +0.61% Intraday chart for Pediatrix Medical Group, Inc. -11.90% -11.61%
May. 07 Transcript : Pediatrix Medical Group, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07 Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q1 Revenue $495.1M, vs. Street Est of $500.4M MT

Evolution of the average Target Price on Pediatrix Medical Group, Inc.

Price target over the last 5 years

History of analyst recommendation changes

66f5e93e82b9d1db7938bb4b0f.WSpEr055GkS1mAkZwGo64LOGRIZ0Ts9iPBXAvuDcXSY.NU883ygTXAyB3ENzoV4Mg4P_EbUNOPgwTVyn3ZivFGMsQx33JB5VJuL-WA~9ef85128d1e3fb5156c058a31eb81787

Analyst Recommendations on Pediatrix Medical Group, Inc.

Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating MT
Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating MT
Mizuho Trims Price Target on Pediatrix Medical to $9 From $10, Maintains Neutral Rating MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $10 From $10.50, Keeps Hold Rating MT
UBS Initiates Coverage on Pediatrix Medical Group With Neutral Rating, $9.50 Price Target MT
Deutsche Bank Cuts Pediatrix Medical Price Target to $9 From $14, Maintains Sell Rating MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $15 From $17, Maintains Hold Rating MT
Deutsche Bank Adjusts Pediatrix Medical Price Target to $14 From $15.50, Maintains Sell Rating MT
Credit Suisse Adjusts Price Target on Pediatrix Medical to $23 From $27, Maintains Outperform Rating MT
Credit Suisse Adjusts Pediatrix Medical Group's Price Target to $27 From $28, Keeps Outperform Rating MT
Mizuho Adjusts Price Target on Pediatrix Medical to $17 From $21, Maintains Neutral Rating MT
SVB Leerink Adjusts Price Target on Pediatrix Medical to $16 From $20, Maintains Market Perform Rating MT
Deutsche Bank Adjusts Pediatrix Medical Group Price Target to $14 From $16, Maintains Sell Rating MT
Credit Suisse Lowers Pediatrix Medical Group's Price Target to $28 from $30 After Lower-than-Expected Q2 EBITDA, Keeps Outperform Rating MT
BMO Capital Lowers Pediatrix Medical Group's Price Target to $23 From $25, Maintains Market Perform Rating MT
S&P Raises Pediatrix Medical Group Rating To 'BB-' On Better Leverage, Stable Growth; Outlook Stable MT
SVB Securities Adjusts Mednax's Price Target to $20 from $24, Keeps Market Perform Rating MT
Deutsche Bank Adjusts Price Target on Mednax to $16 From $24, Maintains Sell Rating MT
Credit Suisse Trims Mednax's PT to $30 from $31, Lowers 2022, 2023 Estimates as Q1 Underperformed Consensus on Ex-Pro Forma Basis; Maintains Outperform Rating MT
Mizuho Adjusts Mednax's Price Target to $23 from $28, Keeps Neutral Rating MT
SVB Leerink Adjusts Mednax's Price Target to $24 from $27, Keeps Market Perform Rating MT
Credit Suisse Lowers Mednax's Price Target to $31 from $32, Maintains Outperform Rating MT
Credit Suisse Lowers Mednax's PT to $32 from $33, Notes Reduced Q1 EBITDA Estimate to Reflect More Traditional Low Double Digit YoY Growth; Keeps Outperform Rating MT
Mizuho Securities Adjusts Price Target on Mednax to $28 From $32, Maintains Neutral Rating MT
SVB Leerink Adjusts Mednax's Price Target to $27 from $29, Keeps Market Perform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
8.22 USD
Average target price
9.071 USD
Spread / Average Target
+10.36%
High Price Target
10 USD
Spread / Highest target
+21.65%
Low Price Target
8 USD
Spread / Lowest Target
-2.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pediatrix Medical Group, Inc.

Jefferies & Co.
Deutsche Bank Securities
Truist Securities
Mizuho Securities
UBS
Credit Suisse
SVB Securities LLC
BMO Capital
SVB Leerink
Stifel Nicolaus
Citigroup

Ratings for Pediatrix Medical Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MD Stock
  4. Consensus Pediatrix Medical Group, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW